Real-world study of posaconazole tablets for the prophylaxis of invasive fungal disease in patients with end-stage liver disease
{{output}}
Background: Data on the pharmacokinetics and tolerability of posaconazole delayed-release tablets in patients with end-stage liver disease (ESLD)(including liver failure and decompensated cirrhosis) remain limited. This study aim... ...
